We invest in institutional quality office, R & D, Life Sciences, and industrial properties in the Western U.S. that appeal to today's modern tenants.
Since 2012, Graymark Capital has purchased 25 office, R&D, Life Science, and industrial properties comprising over 2.7 million square feet and over $1.1 billion of value.